Edition:
United Kingdom

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

59.00EUR
11:40am GMT
Change (% chg)

€-0.40 (-0.67%)
Prev Close
€59.40
Open
€59.20
Day's High
€59.30
Day's Low
€58.30
Volume
22,163
Avg. Vol
113,287
52-wk High
€82.60
52-wk Low
€58.30

Summary

Name Age Since Current Position

Alexandre Merieux

44 2017 Chairman of the Board, Chairman of the Executive Committee, Chief Executive Officer, Non-Independent Director

Guillaume Bouhours

2018 Corporate Vice President, Chief Financial Officer, Member of the Executive Board

Michel Baguenault

2017 Executive Vice-President, Member of the Executive Board, Secretary General, Head of Human Resources, Communications, Legal Affairs and Intellectual Property

Pierre Boulud

2017 Corporate Vice-President, Asia-Pacific Region, Industrial Unit, Investments and Strategic Planning, Member of the Executive Board

Nicolas Cartier

2014 Corporate Vice President Industrial Applications unit, Member of the Executive Board

Pierre Charbonnier

52 Corporate Vice President, Manufacturing & Supply Chain, Member of the Executive Board

Francois Lacoste

2014 Corporate Vice President, Clinical Unit, Member of the Executive Board

Yasha Mitrotti

2015 Corporate Vice President, Europe, Middle East, Africa Region & Worldwide Sales Performance, Member of the Executive Board

Alain Pluquet

2017 Corporate Vice President, Chief Data Analytics Officer, Member of the Executive Board

Randy Rasmussen

Corporate Vice President, Molecular Biology, Member of the Executive Board

Stefan Willemsen

2017 Corporate Vice-President, Americas Region, Member of the Executive Board

Kirk Ririe

Chief Innovation Officer, Member of the Executive Board

Mark Miller

2014 Chief Medical Officer, Member of the Executive Board

Philippe Archinard

58 2010 Non-Independent Director

Jean-Luc Belingard

69 2017 Non-Independent Director

Harold Boel

54 2012 Independent Director

Philippe Gillet

60 2014 Independent Director

Marie-Helene Habert-Dassault

53 2012 Independent Director

Marie-Paule Kieny

63 2017 Independent Director

Agnes Lemarchand

63 2014 Independent Director

Fanny Letier

39 2017 Independent Director

Michele Palladino

78 2004 Independent Director

Sylvain Morgeau

2016 Investor Relations Manager

Biographies

Name Description

Alexandre Merieux

Mr. Alexandre Merieux has served as Chairman of the Board, Chairman of the Executive Committee, Chief Executive Officer, Non-Independent Director since December 15, 2017. He was prior Chief Operating Officer from January 1, 2017 to December 15, 2017. Mr. Alexandre Merieux was Chief Executive Officer, Member of the Management Committee and Director at Biomerieux SA. He previously worked for the Company as Deputy Chief Executive Officer, Corporate Vice President - Industrial Microbiology, Member of the Management Committee and Director from December 19, 2008 to March 31, 2011. Prior to that, he was the Company's Corporate Vice President - Industrial Microbiology, Member of the Management Committee and Director until December 19, 2008. He was first appointed to the Company's Board of Directors on April 16, 2004. From 1999 to 2004, Mr. Merieux served at the Silliker Group Corporation, working in marketing in the United States and Europe and as Marketing and Business Unit director in France. He joined the Industrial Microbiology division of BioMerieux Inc in 2005. Mr. Merieux holds a degree in Biology from Universite Claude Bernard Lyon I and is a graduate of HEC Montreal Business School (HEC Montreal). He currently also holds several other posts, including Chairman of SGH, Director of Fondation Christophe et Rodolphe Merieux and Director of bioMerieux China Ltd., among others.

Guillaume Bouhours

Michel Baguenault

Mr. Michel Baguenault has served as Executive Vice-President and Member of the Executive Board. He has also acted as Secretary General, Head of Human Resources Communications, Legal Affairs and Intellectual Property. He served as Head of Human Resources and Communications, Member of the Management Committee, Member of the Management Board, Secretary of BIOMERIEUX SA. He was Corporate Vice President of Human Resources and Communications, Member of the Management Committee of BIOMERIEUX SA since 2014.

Pierre Boulud

Nicolas Cartier

Mr. Nicolas Cartier has been Corporate Vice President Industrial Applications unit, Member of the Executive Board at BIOMERIEUX SA since 2014. He served as Member of the Management Committee and Director of Industrial Microbiology Unit of Biomerieux SA from May 21, 2013 to 2014. Before joining the Company, Mr. Cartier spent most of his professional career at Sanofi SA. Since 2009, he has been General Manager of Sanofi France. Prior to that, he gained 10 years of international experience through various roles in particular in Thailand, where he was in charge of commercial development for the Southeast Asia region within the Animal Health Division, in Shanghai, where he headed up Sanofi China's Pharmaceutical Division and in Mexico City, where he was General Manager of Sanofi Mexico. In France, Mr. Cartier was Chief of Staff in the office of the Chairman of the Board and Chief Executive Officer of Sanofi France and then Business Unit Manager.

Pierre Charbonnier

Dr. Pierre Charbonnier has served as Corporate Vice President, Manufacturing & Supply Chain, Member of the Executive Board of BIOMERIEUX SA. He has served as Director at PT Merck Tbk. He holds Ph.D in Pharmacy from Universite de Lyon.

Francois Lacoste

Mr. Francois Lacoste has acted as Corporate Vice President, Clinical Unit and Member of the Executive Board of BIOMERIEUX SA since 2014. Between March 31, 2011 and 2014, he served as Member of the Management Committee, Director of Immunoassay Unit at the Company.

Yasha Mitrotti

Mr. Yasha Mitrotti has acted as Corporate Vice President, Europe, Middle East, Africa Region & Worldwide Sales Performance and as Member of the Executive Board of BIOMERIEUX SA since 2015. Previously, he served as Corporate Vice President, Europe, Middle East, Africa Region, Member of the Management Committee at the Company.

Alain Pluquet

Mr. Alain Pluquet has acted as Corporate Vice President, Chief Data Officer, Member of the Executive Board of BIOMERIEUX SA since 2014. He served also as Chief Technology Officer of the Company. He served at Biomerieux SA as Member of the Management Committee, Director of Innovation and Systems Unit from June 2011. Prior to that, he served as the Company's Chief Technology Officer since November 3, 2009. Mr. Pluquet has worked in the CEA network since 1994. Before joining the Company, he was Head of the Signal and Capturing Technology Department at the CEA LIST (Laboratory for system and technology integration). He has a Ph.D. degree in Nuclear Physics from Fermilab and the CEA (French Atomic Energy Commission). He also holds a Master degree in Fields-Particles-Matter from Ecole Polytechnique and Universite Paris VI, VII and XI.

Randy Rasmussen

Mr. Randy Rasmussen has served as Corporate Vice President, Molecular Biology, Member of the Executive Board of BIOMERIEUX SA.

Stefan Willemsen

Mr. Stefan Willemsen has acted as Corporate Vice-President, Americas Region and Member of the Executive Board of BIOMERIEUX SA since 2017. He was Corporate Vice President, Americas Region, Group Chief Legal Officer and Member of the Executive Board of BIOMERIEUX SA from 2014 to 2017. Previously, he served as Member of the Management Committee, Director of Business Development, Legal Affairs and Industrial Property at the Company.

Kirk Ririe

Mark Miller

Mr. Mark Miller has acted as Chief Medical Officer and Member of the Executive Board of BIOMERIEUX SA since 2014. Previously, he served as Member of the Management Committee, Chief Medical Officer and Head of Regulatory Affairs and before that he was Member of the Management Committee and Chief Medical Officer at the company.

Philippe Archinard

Mr. Philippe Archinard has served as Non-Independent Director of Biomerieux SA since June 10, 2010. He has also served as Member of the Audit Committee. He was previously Director - Representative of T.S.G.H. at the Company from April 16, 2004 until June 10, 2010. Mr. Archinard graduated from the Harvard Business School (Harvard University). He was Managing Director of Innogenetics from 2000 to 2003. He is Member of the Audit Committee and the Innovation and Technological Breakthroughs Committee at the Company and Director of the Immunotherapy division of Institut Merieux. He has held several other posts, including Chief Executive Officer of TSGH, Director of Erytech Pharma and Vice Chairman of BioAster, among others.

Jean-Luc Belingard

Mr. Jean-Luc Belingard has served as Non-Independent Director of BIOMERIEUX SA from January 1, 2017. He also has served as Chairman of the Strategy Committee, Member of the Human Resources, Appointment and Compensation Committee of the Company since January 1, 2017. Mr. Jean-Luc Belingard acted as Chairman of the Board of BIOMERIEUX SA from 2014 to January 1, 2017. Prior to that, he served at Biomerieux SA as Chairman of the Board and Chief Executive Officer, Member of the Management Committee from July 20, 2011. Prior to that he was the Company's Chairman of the Board of Directors since January 1, 2011. He was previously Independent Director of the Company from September 15, 2006 until December 31, 2010. He was Member of the Management Board and Managing Director of Pierre Fabre from 1999 to 2001. He was then Chairman of the Board and Chief Executive Officer of IPSEN from 2001 until 2010. Mr. Belingard graduated from Hautes Etudes Commerciales (1971) and holds an MBA degree from Cornell University (1974). He has also served as Director of LabCorp of America, Stallergenes, AES Laboratoire Groupe SA and AES Chemunex SA.

Harold Boel

Mr. Harold Boel has served Independent Director of Biomerieux SA since May 30, 2012. He has acted as Chairman of the Company's Audit Committee. He graduated from Ecole Polytechnique Federale de Lausanne with an engineering degree in Materials Science and Engineering and from the Brown University with a Bachelor of Science degree in Chemistry. He has served as Deputy Director of Sofina, Henex, Suez Environnement Caledonia Investment , Societe de Participations Industrielles and Merieux NutriSciences Corporation, among others.

Philippe Gillet

Mr. Philippe Gillet has acted as Independent Director of Biomerieux SA since May 28, 2014. He has served as Member of the Strategy Committee. He is a graduate of l’Ecole Normale Superieure de Paris and earned a Ph.D. in geophysics and geochemistry as well as a State doctorate in geosciences. He was a professor of geophysics at the University of Rennes prior to becoming Director of l’Ecole Normale Superieure de Lyon, where he was also a professor of Earth Sciences. In addition, from May 2007 to April 2010 he served as Chief of Staff for the French Minister of Higher Education and Research. He subsequently joined l’Ecole Polytechnique Federale of Lausanne, where he has served as Vice President for Academic Affairs. At the same time, he continues his teaching activities as a professor and directs the Earth and Planetary Sciences Laboratory.

Marie-Helene Habert-Dassault

Ms. Marie-Helene Habert-Dassault has served Independent Director of Biomerieux SA since May 30, 2012. She has acted as Member of the Human Resources, Appointment and Compensation Committee at the Company. She holds a degree in Business Law from Universite Paris II Pantheon-Assas, a DESS degree in Business Law and Taxing from Universite de Paris I Pantheon Sorbonne and a DESS degree in Marketing from Institut d'Etudes Politiques de Paris. In addition to her duties at the Company, she has held several other posts, including Director of Artcurial, Manager of H Investissements and Vice Chairman and Member of the Supervisory Board of Groupe Industriel Marcel Dassault, among others.

Marie-Paule Kieny

Ms. Marie-Paule Kieny has served as Independent Director of Biomerieux SA since August 28, 2017. She has acted as Member of the Strategy Committee since August, 28, 2017. She served as Assistant Director General of the WHO from 2010 to 2017. She also underwent a High Performance Boards training at IMD, Lausanne, Switzerland, in 2016. She acted as Chair of the Board of the Foundation Drugs for Neglected Diseases Initiative, Geneva, Switzerland and as Chairman of the Board of the Medicines Patent Pool Foundation, Geneva. She also served as Board member of the Human Vaccine Project, New York, US.

Agnes Lemarchand

Ms. Agnes Lemarchand has been Independent Director of Biomerieux SA since May 28, 2014. She has acted as Member of the Audit Committee at the Company. She is a graduate of ENSCP (Ecole Nationale Superieure de Chimie de Paris), Massachusetts Institute of Technology, and INSEAD. She has spent her career in industry. She has served as Chief Executive Officer of Industrie Biologique Francaise (a joint venture between the Rhone-Poulenc group and Institut Merieux), Chairman and Chief Executive Officer of Prodical (a subsidiary of the Ciments Français group), and Chairman and Chief Executive Officer of the Lafarge group’s lime business. In 2005, together with the key employees, she took over the Lafarge UK lime business and founded Steetley Dolomite Ltd (UK), where she has served Chairman. In addition, she has been Director on the Saint-Gobain Board of Directors and sits on the CGG Board of Directors. She has acted as Member of the Supervisory Boards of both Areva and Siclae (where she represents Bpifrance). She has also been member of the steering committee of the 34 Plans de la Nouvelle France Industrielle.

Fanny Letier

Ms. Fanny Letier has acted as Independent Director of BIOMERIEUX SA since May 30, 2017. She has served as Chairman Of The Human Resources, Appointment and Compensation Committee since May 30, 2017. She graduated in Sciences Politiques Paris. She acted as Civilian Director at the French Treasury Department (Ministry of Finance). She was Secretary General of the Inter-Ministry Committee on Industrial Restructuring (CIRI) from 2009 to 2012. Later she served as Deputy director of the office of the Minister of Industrial Recovery from 2012 to 2013. She acted as Director then Executive Director of the French Regional Investment funds of Bpifrance.

Michele Palladino

Mr. Michele Palladino has acted as Independent Director of Biomerieux SA since July 6, 2004. He has served as Member of the Strategy Committee. He served as Member of the Company's Human Resources, Nominating and Remuneration Committee. He was Chief Executive Officer of the Company until 1993. He has also been Chairman and Manager of Michele Palladino & C SAS.

Sylvain Morgeau